Evidence map›Paper›PMID 40561010›Full record

ArticleScience advances2025

Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression.

Ruizhi Hu, Junchang Qin, Wei Feng, Xinran Song, Hui Huang, Chen Dai, Bo Zhang, Yu Chen

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Review
  2. Nanomaterials-Based Immunotherapy for Atherosclerosis.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruizhi HuDepartment of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P. R. China.ORCID 0000-0003-1512-1414
Junchang QinDepartment of Ultrasound, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, P. R. China.ORCID 0000-0002-8059-5862
Wei FengMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0002-8304-2737
Xinran SongMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0009-0009-9704-9794
Hui HuangMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0009-0005-3662-686X
Chen DaiDepartment of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P. R. China.ORCID 0009-0009-8102-8470
Bo ZhangDepartment of Ultrasound, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, P. R. China.ORCID 0000-0002-0607-6044
Yu ChenMaterdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, P. R. China.ORCID 0000-0002-8206-3325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophage pyroptosis has been identified as a critical pathological mechanism in inflammation-related atherosclerosis (AS). In this work, we have demonstrated that Zn

Indexed as

AtherosclerosisLysosomesMacrophagesNanoparticlesPyroptosisZincAnimalsDisease ProgressionHumansMiceRAW 264.7 CellsReactive Oxygen SpeciesTransient Receptor Potential ChannelsReactive Oxygen SpeciesTransient Receptor Potential ChannelsZinc

Identifiers

PMID40561010
PMCPMC12189970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.